Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2467-2472
Published online before print August 31, 2006, doi: 10.1161/01.STR.0000240689.15109.47
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/10/2467    most recent
01.STR.0000240689.15109.47v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perry, J. J.
Right arrow Articles by Symington, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perry, J. J.
Right arrow Articles by Symington, C.
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Aneurysm, AVM, hematoma
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2006;37:2467.)
© 2006 American Heart Association, Inc.


Original Contributions

Should Spectrophotometry Be Used to Identify Xanthochromia in the Cerebrospinal Fluid of Alert Patients Suspected of Having Subarachnoid Hemorrhage?

Jeffrey J. Perry, MD, MSc; Marco L.A. Sivilotti, MD, MSc; Ian G. Stiell, MD, MSc; George A. Wells, PhD; Jenny Raymond, PhD; Melodie Mortensen, BScRN Cheryl Symington, RN, ENCc

From the Department of Emergency Medicine (J.J.P., I.G.S., M.M., C.S.), University of Ottawa, ON, Canada; the Departments of Emergency Medicine and of Pharmacology & Toxicology (M.L.A.S.), Queen’s University, Kingston, ON, Canada; the Department of Epidemiology and Community Medicine (G.A.W.), University of Ottawa, ON, Canada; the Department of Pathology and Molecular Medicine (J.R.), Queen’s University, Kingston, ON, Canada; and the Department of Emergency Medicine, University of Ottawa, ON, Canada.

Correspondence to Jeffrey J. Perry, The Ottawa Hospital, 1053 Carling Ave, F6 Ottawa, ON, Canada K1Y4E9. E-mail jperry{at}ohri.ca

Background and Purpose— The absence of xanthochromia in the cerebrospinal fluid (CSF) is often used to exclude subarachnoid hemorrhage (SAH). Authorities advocate spectrophotometry to measure xanthochromia, but most North American hospitals use visual inspection. We studied the diagnostic accuracy of spectrophotometry for SAH, and its potential impact on current practice.

Methods— This was a prospective cohort study comparing the diagnostic accuracy of tests. The study was set in 3 university-affiliated tertiary care emergency departments. We enrolled consecutive neurologically intact adults with nontraumatic headache undergoing lumbar puncture (LP) to rule out SAH. CSF was centrifuged, frozen and analyzed later in batch. SAH was defined by (1) subarachnoid blood on CT, (2) >5x106 red blood cells/L in the final CSF tube and positive angiography, or (3) visible xanthochromia in CSF and positive angiography. All subjects lacking a normal CT and LP were telephoned at 30 days.

Results— We enrolled 220 patients (mean age 42±16 years; CT rate 87.7%; angiography rate 5.9%). Two SAHs were identified: 1 with red blood cells without xanthochromia in the CSF and 1 with visibly xanthochromic CSF. The specificity of xanthochromia was 97% (95% CI: 92% to 99%) for visual inspection, but as low as 29% (95% CI: 23% to 35%) for 2 of the spectrophotometric definitions. Introducing spectrophotometry could lead to angiography in as many as 11% to 71% of patients undergoing LP.

Conclusions— Spectrophotometric definitions of xanthochromia have only moderate to low specificity for SAH. Using spectrophotometry could increase angiography rates, thereby identifying more incidental aneurysms, increasing patient anxiety and exposing patients to unnecessary surgical or investigational complications without benefit.


Key Words: cerebrospinal fluid • spectrophotometry • subarachnoid hemorrhage




This article has been cited by other articles:


Home page
Emerg. Med. J.Home page
EMQ answers
Emerg. Med. J., July 1, 2008; 25(7): 464 - 464.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
I. D Watson, R. Beetham, M. N Fahie-Wilson, I. B Holbrook, and D. M O'Connell
What is the role of cerebrospinal fluid ferritin in the diagnosis of subarachnoid haemorrhage in computed tomography-negative patients?
Ann Clin Biochem, March 1, 2008; 45(2): 189 - 192.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. E. Nigrovic, M. Trivedi, J. A. Edlow, and M. I. Neuman
Cerebrospinal Fluid Xanthochromia in Newborns Is Related to Maternal Labor Before Delivery
Pediatrics, November 1, 2007; 120(5): e1212 - e1216.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Beetham and S. Lhatoo
Should Spectrophotometry Be Used to Identify Xanthochromia in the Cerebrospinal Fluid of Alert Patients Suspected of Having Subarachnoid Hemorrhage?
Stroke, September 1, 2007; 38(9): e86 - e86.
[Full Text] [PDF]


Home page
StrokeHome page
J. J. Perry and M. L.A. Sivilotti
Response to Letter by Beetham and Lhatoo
Stroke, September 1, 2007; 38(9): e87 - e87.
[Full Text] [PDF]